Legal procedure

ARDX DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit

Retrieved on: 
Wednesday, August 4, 2021

The Ardelyx class action lawsuit charges Ardelyx and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Ardelyx class action lawsuit charges Ardelyx and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you wish to serve as lead plaintiff of the Ardelyx class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the Ardelyx class action lawsuit must be filed with the court no later than September 28, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the Ardelyx class action lawsuit.

Docket Alarm Provides Half A Billion Documents for Legal Analytics and Insights

Retrieved on: 
Wednesday, August 4, 2021

WASHINGTON, Aug. 4, 2021 /PRNewswire-PRWeb/ -- Docket Alarm by Fastcase , a leader in litigation analytics and data-based judicial profiles, announced today it has reached a milestone of making half a billion legal documents available for litigators and subscribers gathering legal analytics and insights.

Key Points: 
  • WASHINGTON, Aug. 4, 2021 /PRNewswire-PRWeb/ -- Docket Alarm by Fastcase , a leader in litigation analytics and data-based judicial profiles, announced today it has reached a milestone of making half a billion legal documents available for litigators and subscribers gathering legal analytics and insights.
  • Docket Alarm is a national leader in docket research and legal analytics.
  • Docket Alarm was acquired by Fastcase in January 2018, and continues to be a disruptor in the legal analytics market.
  • The company provides an innovative research suite of primary law, dockets, treatises, legal blogs, analytics, workflow tools, and legal news.

NCLA Celebrates Jury Verdict Exonerating Our Clients from a Dozen Inaccurate SEC Charges

Retrieved on: 
Friday, July 30, 2021

SEC targeted Spartan, a market maker, and Island, a transfer agent, for third-party misconduct that SEC itself had failed to uncover.

Key Points: 
  • SEC targeted Spartan, a market maker, and Island, a transfer agent, for third-party misconduct that SEC itself had failed to uncover.
  • NCLA believes that the sole remaining count against our clients is legally unsupported and will be successfully overturned upon filing a post-verdict motion.
  • Todays verdict should be a signal to SEC that ordinary people will not stand for its abuses.
  • Over the past three weeks, our clients finally got the opportunity to tell their stories to an impartial jury.

ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit

Retrieved on: 
Saturday, July 31, 2021

The Ardelyx class action lawsuit charges Ardelyx and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Ardelyx class action lawsuit charges Ardelyx and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you wish to serve as lead plaintiff of the Ardelyx class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the Ardelyx class action lawsuit must be filed with the court no later than September 28, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the Ardelyx class action lawsuit.

CRMD SHAREHOLDER ALERT: Investors with Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit

Retrieved on: 
Friday, July 30, 2021

The CorMedix class action lawsuit charges CorMedix and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The CorMedix class action lawsuit charges CorMedix and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you wish to serve as lead plaintiff of the CorMedix class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the CorMedix class action lawsuit must be filed with the court no later than September 20, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the CorMedix class action lawsuit.

BZ NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Kanzhun Limited Class Action Lawsuit

Retrieved on: 
Thursday, July 29, 2021

The Kanzhun class action lawsuit charges Kanzhun and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Kanzhun class action lawsuit charges Kanzhun and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you suffered substantial losses and wish to serve as lead plaintiff of the Kanzhun class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the Kanzhun class action lawsuit must be filed with the court no later than September 10, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the Kanzhun class action lawsuit.

PIEDMONT LITHIUM INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Piedmont Lithium Inc.

Retrieved on: 
Tuesday, July 27, 2021

All investors who purchased Piedmont Lithium Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased Piedmont Lithium Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com .
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

CARLOTZ ALERT: Investors With Substantial Losses Have Opportunity to Lead the CarLotz, Inc. Class Action Lawsuit – LOTZ

Retrieved on: 
Monday, July 26, 2021

The CarLotz class action lawsuit charges CarLotz and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The CarLotz class action lawsuit charges CarLotz and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you wish to serve as lead plaintiff of the CarLotz class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the CarLotz class action lawsuit must be filed with the court no later than September 7, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the CarLotz class action lawsuit.

Court Issues Contempt Orders, Strikes Testimony of Key Witness in Baby Powder-Ovarian Cancer Trial

Retrieved on: 
Monday, July 26, 2021

After issuing the contempt orders, Judge Kolker struck all previous testimony by Dr. Nicholson and advised the jury to disregard her comments, stating on the record that he did not find her to be a credible witness.

Key Points: 
  • After issuing the contempt orders, Judge Kolker struck all previous testimony by Dr. Nicholson and advised the jury to disregard her comments, stating on the record that he did not find her to be a credible witness.
  • At the conclusion of Friday's hearing, over the objections of J&J's defense counsel, Dr. Nicholson was ordered to appear and resume cross-examination testimony as a defense witness.
  • Dozens of peer-reviewed medical studiespublished in the last 35 yearshavefounda statistically significant correlation between talcum powder use and ovarian cancer.
  • In addition, testimony is scheduled to begin in April 2022 in multidistrict litigation in New Jersey federal court, which has consolidated more than 30,000 ovarian cancer claims against J&J.

CRMD ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit

Retrieved on: 
Saturday, July 24, 2021

The CorMedix class action lawsuit charges CorMedix and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • The CorMedix class action lawsuit charges CorMedix and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • If you wish to serve as lead plaintiff of the CorMedix class action lawsuit, please provide your information by clicking here .
  • Lead plaintiff motions for the CorMedix class action lawsuit must be filed with the court no later than September 20, 2021.
  • A lead plaintiff acts on behalf of all other class members in directing the CorMedix class action lawsuit.